{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:10:40Z","timestamp":1771632640451,"version":"3.50.1"},"reference-count":82,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"5095","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science"],"published-print":{"date-parts":[[1993,1,29]]},"abstract":"<jats:p>The use of oral contraceptives in the United States during the past three decades has led to a dramatic decline in the incidence of cancers of the ovary and endometrium. The magnitude of these declines was predictable both from epidemiologic data and from the biologic effects of oral contraceptives on these tissues. Although the incidence of breast cancer has not been substantially affected by current oral contraceptives, it may be possible to develop alternative forms of contraception that provide protection against all three cancers. The major goal of hormonal chemoprevention of cancer is to reduce cell proliferation in the relevant epithelial tissue. New chemopreventive agents such as tamoxifen exemplify the application of this principle.<\/jats:p>","DOI":"10.1126\/science.8381558","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T23:05:09Z","timestamp":1160089509000},"page":"633-638","source":"Crossref","is-referenced-by-count":161,"title":["Hormonal Chemoprevention of Cancer in Women"],"prefix":"10.1126","volume":"259","author":[{"given":"Brian E.","family":"Henderson","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine and the Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles, CA 90033."}]},{"given":"Ronald K.","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and the Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles, CA 90033."}]},{"given":"Malcolm C.","family":"Pike","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and the Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles, CA 90033."}]}],"member":"221","reference":[{"key":"e_1_2_1_1_1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/bjc.1988.137","volume":"57","year":"1988","unstructured":"BRIT J CANCER 57: 604 (1988).","journal-title":"BRIT J CANCER"},{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/bjc.1988.138","volume":"57","year":"1988","unstructured":"BRIT J CANCER 57: 608 (1988).","journal-title":"BRIT J CANCER"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/jama.1983.03330360040033","volume":"249","year":"1983","unstructured":"JAMA-J AM MED ASSOC 249: 1600 (1983).","journal-title":"JAMA-J AM MED ASSOC"},{"key":"e_1_2_1_4_1","first-page":"796","volume":"249","year":"1987","unstructured":"JAMA-J AM MED ASSOC 249: 796 (1987).","journal-title":"JAMA-J AM MED ASSOC"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jama.1987.03390060086029","volume":"257","year":"1987","unstructured":"JAMA-J AM MED ASSOC 257: 796 (1987).","journal-title":"JAMA-J AM MED ASSOC"},{"key":"e_1_2_1_6_1","first-page":"171","volume":"2","year":"1987","unstructured":"LANCET 2: 171 (1987).","journal-title":"LANCET"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJM198812293192601","volume":"319","year":"1988","unstructured":"NEW ENGLAND JOURNAL OF MEDICINE 319: 1681 (1988).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"issue":"89","key":"e_1_2_1_8_1","first-page":"52","year":"1989","unstructured":"U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES PUBLICATION 89-1232 52 (1989).","journal-title":"U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES PUBLICATION"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0046-8177(89)80003-6","volume":"20","year":"1989","unstructured":"ANDERSON, T.J., ORAL-CONTRACEPTIVE USE INFLUENCES RESTING BREAST PROLIFERATION, HUMAN PATHOLOGY 20: 1139 (1989).","journal-title":"HUMAN PATHOLOGY"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198908033210505","volume":"321","year":"1989","unstructured":"BERGKVIST, L, THE RISK OF BREAST-CANCER AFTER ESTROGEN AND ESTROGEN PROGESTIN REPLACEMENT, NEW ENGLAND JOURNAL OF MEDICINE 321: 293 (1989).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/bjc.1986.246","volume":"54","year":"1986","unstructured":"BRINTON, L.A., MENOPAUSAL ESTROGENS AND BREAST-CANCER RISK - AN EXPANDED CASE-CONTROL STUDY, BRITISH JOURNAL OF CANCER 54: 825 (1986).","journal-title":"BRITISH JOURNAL OF CANCER"},{"key":"e_1_2_1_12_1","first-page":"170","volume":"2","year":"1979","unstructured":"CASAGRANDE, J.T., INCESSANT OVULATION AND OVARIAN-CANCER, LANCET 2: 170 (1979).","journal-title":"LANCET"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM198606193142505","volume":"314","year":"1986","unstructured":"CHERKOWSKI, R, NEW ENGLAND JOURNAL OF MEDICINE 314: 1615 (1986).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF00051356","volume":"3","year":"1992","unstructured":"COLDITZ, G. A., CANCER CAUSES & CONTROL 3: 433 (1992).","journal-title":"CANCER CAUSES & CONTROL"},{"key":"e_1_2_1_15_1","first-page":"119","year":"1986","unstructured":"Cummings, F. J., Proceedings of the NIH Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy tor Breast Cancer: 119 (1986).","journal-title":"Proceedings of the NIH Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy tor Breast Cancer"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/ijc.2910420606","volume":"42","year":"1988","unstructured":"EWERTZ, M, INFLUENCE OF NON-CONTRACEPTIVE EXOGENOUS AND ENDOGENOUS SEX-HORMONES ON BREAST-CANCER RISK IN DENMARK, INTERNATIONAL JOURNAL OF CANCER 42: 832 (1988).","journal-title":"INTERNATIONAL JOURNAL OF CANCER"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1200\/JCO.1990.8.4.599","volume":"8","year":"1990","unstructured":"FALKSON, H.C., ADJUVANT TRIAL OF 12 CYCLES OF CMFPT FOLLOWED BY OBSERVATION OR CONTINUOUS TAMOXIFEN VERSUS 4 CYCLES OF CMFPT IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER - AN EASTERN COOPERATIVE ONCOLOGY GROUP PHASE-III STUDY, JOURNAL OF CLINICAL ONCOLOGY 8: 599 (1990).","journal-title":"JOURNAL OF CLINICAL ONCOLOGY"},{"key":"e_1_2_1_18_1","first-page":"163","volume":"2","year":"1971","unstructured":"FATHALLA, M.F., INCESSANT OVULATION - FACTOR IN OVARIAN NEOPLASIA, LANCET 2: 163 (1971).","journal-title":"LANCET"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","volume":"320","year":"1989","unstructured":"FISHER, B, A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS, NEW ENGLAND JOURNAL OF MEDICINE 320: 479 (1989).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_20_1","first-page":"117","volume":"1","year":"1989","unstructured":"FORNANDER, T, ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER - OCCURRENCE OF NEW PRIMARY CANCERS, LANCET 1: 117 (1989).","journal-title":"LANCET"},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0002-9378(83)90754-8","volume":"146","year":"1983","unstructured":"GAL, D, LONG-TERM EFFECT OF MEGESTROL-ACETATE IN THE TREATMENT OF ENDOMETRIAL HYPERPLASIA, AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 146: 316 (1983).","journal-title":"AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY"},{"key":"e_1_2_1_22_1","first-page":"531","volume":"27","year":"1982","unstructured":"GAMBRELL, R.D., CLINICAL USE OF PROGESTINS IN THE MENOPAUSAL PATIENT - DOSAGE AND DURATION, JOURNAL OF REPRODUCTIVE MEDICINE 27: 531 (1982).","journal-title":"JOURNAL OF REPRODUCTIVE MEDICINE"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archinte.1991.00400010095012","volume":"151","year":"1991","unstructured":"HENDERSON, B.E., DECREASED MORTALITY IN USERS OF ESTROGEN REPLACEMENT THERAPY, ARCHIVES OF INTERNAL MEDICINE 151: 75 (1991).","journal-title":"ARCHIVES OF INTERNAL MEDICINE"},{"key":"e_1_2_1_24_1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bjc.1983.127","volume":"47","year":"1983","unstructured":"HENDERSON, B.E., THE EPIDEMIOLOGY OF ENDOMETRIAL CANCER IN YOUNG-WOMEN, BRITISH JOURNAL OF CANCER 47: 749 (1983).","journal-title":"BRITISH JOURNAL OF CANCER"},{"key":"e_1_2_1_25_1","first-page":"3232","volume":"42","year":"1982","unstructured":"HENDERSON, B.E., ENDOGENOUS HORMONES AS A MAJOR FACTOR IN HUMAN CANCER, CANCER RESEARCH 42: 3232 (1982).","journal-title":"CANCER RESEARCH"},{"key":"e_1_2_1_26_1","first-page":"246","volume":"48","year":"1988","unstructured":"HENDERSON, B.E., ESTROGENS AS A CAUSE OF HUMAN CANCER - THE RICHARD-AND-HINDA-ROSENTHAL-FOUNDATION AWARD LECTURE, CANCER RESEARCH 48: 246 (1988).","journal-title":"CANCER RESEARCH"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1957166"},{"key":"e_1_2_1_28_1","first-page":"139","volume":"54","year":"1984","unstructured":"HIATT, R.A., EXOGENOUS ESTROGEN AND BREAST-CANCER AFTER BILATERAL OOPHORECTOMY, CANCER 54: 139 (1984).","journal-title":"CANCER"},{"key":"e_1_2_1_29_1","first-page":"815","volume":"67","year":"1981","unstructured":"HOOVER, R, CONJUGATED ESTROGENS AND BREAST-CANCER RISK IN WOMEN, JOURNAL OF THE NATIONAL CANCER INSTITUTE 67: 815 (1981).","journal-title":"JOURNAL OF THE NATIONAL CANCER INSTITUTE"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-9378(87)90204-3","volume":"156","year":"1987","unstructured":"JENSEN, J, LONG-TERM EFFECTS OF PERCUTANEOUS ESTROGENS AND ORAL PROGESTERONE ON SERUM-LIPOPROTEINS IN POSTMENOPAUSAL WOMEN, AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 156: 66 (1987).","journal-title":"AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY"},{"key":"e_1_2_1_31_1","first-page":"1","year":"1990","unstructured":"Jordan, V. C., Cancer Prevention: 1 (1990).","journal-title":"Cancer Prevention"},{"key":"e_1_2_1_32_1","first-page":"4517","volume":"47","year":"1987","unstructured":"JORDAN, V.C., LONG-TERM ADJUVANT THERAPY WITH TAMOXIFEN - EFFECTS ON SEX-HORMONE BINDING GLOBULIN AND ANTITHROMBIN-III, CANCER RESEARCH 47: 4517 (1987).","journal-title":"CANCER RESEARCH"},{"key":"e_1_2_1_33_1","first-page":"315","volume":"62","year":"1978","unstructured":"KAISERKUPFER, M.I., TAMOXIFEN RETINOPATHY, CANCER TREATMENT REPORTS 62: 315 (1978).","journal-title":"CANCER TREATMENT REPORTS"},{"key":"e_1_2_1_34_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bjc.1988.44","volume":"57","year":"1988","unstructured":"KEY, TJA, THE DOSE-EFFECT RELATIONSHIP BETWEEN UNOPPOSED ESTROGENS AND ENDOMETRIAL MITOTIC RATE - ITS CENTRAL ROLE IN EXPLAINING AND PREDICTING ENDOMETRIAL CANCER RISK, BRITISH JOURNAL OF CANCER 57: 205 (1988).","journal-title":"BRITISH JOURNAL OF CANCER"},{"key":"e_1_2_1_35_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0277-5379(88)90173-3","volume":"24","year":"1988","unstructured":"KEY, TJA, THE ROLE OF ESTROGENS AND PROGESTAGENS IN THE EPIDEMIOLOGY AND PREVENTION OF BREAST-CANCER, EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY 24: 29 (1988).","journal-title":"EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY"},{"key":"e_1_2_1_36_1","first-page":"887","volume":"68","year":"1984","unstructured":"LIPTON, A, VENOUS THROMBOSIS AS A SIDE-EFFECT OF TAMOXIFEN TREATMENT, CANCER TREATMENT REPORTS 68: 887 (1984).","journal-title":"CANCER TREATMENT REPORTS"},{"key":"e_1_2_1_37_1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000478-198606000-00003","volume":"10","year":"1986","unstructured":"LONGACRE, T.A., A CORRELATIVE MORPHOLOGICAL-STUDY OF HUMAN-BREAST AND ENDOMETRIUM IN THE MENSTRUAL-CYCLE, AMERICAN JOURNAL OF SURGICAL PATHOLOGY 10: 382 (1986).","journal-title":"AMERICAN JOURNAL OF SURGICAL PATHOLOGY"},{"key":"e_1_2_1_38_1","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/0277-5379(89)90351-9","volume":"25","year":"1989","unstructured":"LONGSTAFF, S, A CONTROLLED-STUDY OF THE OCULAR EFFECTS OF TAMOXIFEN IN CONVENTIONAL DOSAGE IN THE TREATMENT OF BREAST-CARCINOMA, EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY 25: 1805 (1989).","journal-title":"EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY"},{"key":"e_1_2_1_39_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF01811242","volume":"12","year":"1988","unstructured":"LOVE, R.R., BONE-MINERAL DENSITY IN WOMEN WITH BREAST-CANCER TREATED WITH ADJUVANT TAMOXIFEN FOR AT LEAST 2 YEARS, BREAST CANCER RESEARCH AND TREATMENT 12: 297 (1988).","journal-title":"BREAST CANCER RESEARCH AND TREATMENT"},{"key":"e_1_2_1_40_1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/jnci\/82.16.1327","volume":"82","year":"1990","unstructured":"LOVE, R.R., EFFECTS OF TAMOXIFEN THERAPY ON LIPID AND LIPOPROTEIN LEVELS IN POSTMENOPAUSAL PATIENTS WITH NODE-NEGATIVE BREAST-CANCER, JOURNAL OF THE NATIONAL CANCER INSTITUTE 82: 1327 (1990).","journal-title":"JOURNAL OF THE NATIONAL CANCER INSTITUTE"},{"key":"e_1_2_1_41_1","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1056\/NEJM197606032942304","volume":"294","year":"1976","unstructured":"MACK, T.M., ESTROGENS AND ENDOMETRIAL CANCER IN A RETIREMENT COMMUNITY, NEW ENGLAND JOURNAL OF MEDICINE 294: 1262 (1976).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_42_1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/bmj.303.6800.435","volume":"303","year":"1991","unstructured":"MCDONALD, C.C., FATAL MYOCARDIAL-INFARCTION IN THE SCOTTISH ADJUVANT TAMOXIFEN TRIAL, BRITISH MEDICAL JOURNAL 303: 435 (1991).","journal-title":"BRITISH MEDICAL JOURNAL"},{"key":"e_1_2_1_43_1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/jnci\/83.20.1450","volume":"83","year":"1991","unstructured":"NAYFIELD, S.G., POTENTIAL ROLE OF TAMOXIFEN IN PREVENTION OF BREAST-CANCER, JOURNAL OF THE NATIONAL CANCER INSTITUTE 83: 1450 (1991).","journal-title":"JOURNAL OF THE NATIONAL CANCER INSTITUTE"},{"key":"e_1_2_1_44_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ijc.2910370109","volume":"37","year":"1986","unstructured":"NOMURA, AMY, THE ASSOCIATION OF REPLACEMENT ESTROGENS WITH BREAST-CANCER, INTERNATIONAL JOURNAL OF CANCER 37: 49 (1986).","journal-title":"INTERNATIONAL JOURNAL OF CANCER"},{"key":"e_1_2_1_45_1","first-page":"749","volume":"70","year":"1987","unstructured":"NOTELOVITZ, M, METABOLIC AND HORMONAL EFFECTS OF 25-MG AND 50-MG 17-BETA-ESTRADIOL IMPLANTS IN SURGICALLY MENOPAUSAL WOMEN, OBSTETRICS AND GYNECOLOGY 70: 749 (1987).","journal-title":"OBSTETRICS AND GYNECOLOGY"},{"key":"e_1_2_1_46_1","first-page":"43","volume":"17","year":"1985","unstructured":"PALSHOF, T, REVIEWS ON ENDOCRINE-RELATED CANCER 17 Supplement: 43 (1985).","journal-title":"REVIEWS ON ENDOCRINE-RELATED CANCER"},{"key":"e_1_2_1_47_1","first-page":"2961","volume":"60","year":"1992","unstructured":"PAVLIDIS, N.A., CANCER 60: 2961 (1992).","journal-title":"CANCER"},{"key":"e_1_2_1_48_1","first-page":"1044","volume":"340","year":"1992","unstructured":"PERSSON, I, COMBINED ESTROGEN-PROGESTOGEN REPLACEMENT AND BREAST-CANCER RISK, LANCET 340: 1044 (1992).","journal-title":"LANCET"},{"key":"e_1_2_1_49_1","first-page":"155","volume":"20","year":"1978","unstructured":"PHARRISS, B.B., CLINICAL EXPERIENCE WITH INTRA-UTERINE PROGESTERONE CONTRACEPTIVE SYSTEM, JOURNAL OF REPRODUCTIVE MEDICINE 20: 155 (1978).","journal-title":"JOURNAL OF REPRODUCTIVE MEDICINE"},{"key":"e_1_2_1_50_1","first-page":"292","year":"1983","unstructured":"Pike, M. C., Current Therapy in Oncology: 292 (1983).","journal-title":"Current Therapy in Oncology"},{"key":"e_1_2_1_51_1","unstructured":"Pike M. C. Contraception (1992)."},{"key":"e_1_2_1_52_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0021-9681(87)80009-7","volume":"40","year":"1987","unstructured":"PIKE, M.C., J CHRON DIS 40 2: 59 (1987).","journal-title":"J CHRON DIS"},{"key":"e_1_2_1_53_1","first-page":"264","volume":"1","year":"1986","unstructured":"PIKE, M. C., LANCET 1: 264 (1986).","journal-title":"LANCET"},{"key":"e_1_2_1_54_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ije\/16.2.215","volume":"16","year":"1987","unstructured":"PIPER, J.M., ORAL-CONTRACEPTIVES IN THE UNITED-STATES - TRENDS IN CONTENT AND POTENCY, INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 16: 215 (1987).","journal-title":"INTERNATIONAL JOURNAL OF EPIDEMIOLOGY"},{"key":"e_1_2_1_55_1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/bjc.1988.185","volume":"58","year":"1988","unstructured":"POTTEN, C.S., THE EFFECT OF AGE AND MENSTRUAL-CYCLE UPON PROLIFERATIVE ACTIVITY OF THE NORMAL HUMAN-BREAST, BRITISH JOURNAL OF CANCER 58: 163 (1988).","journal-title":"BRITISH JOURNAL OF CANCER"},{"key":"e_1_2_1_56_1","first-page":"7415","volume":"50","year":"1990","unstructured":"PRESTONMARTIN, S, INCREASED CELL-DIVISION AS A CAUSE OF HUMAN CANCER, CANCER RESEARCH 50: 7415 (1990).","journal-title":"CANCER RESEARCH"},{"key":"e_1_2_1_57_1","first-page":"391","year":"1987","unstructured":"Pritchard, K. I., Adjuvant Therapy of Cancer: 391 (1987).","journal-title":"Adjuvant Therapy of Cancer"},{"key":"e_1_2_1_58_1","unstructured":"Ries L. A. G Cancer Statistics Review 1973-1987 (1990)."},{"key":"e_1_2_1_59_1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5694\/j.1326-5377.1988.tb99427.x","volume":"148","year":"1988","unstructured":"ROHAN, T.E., NON-CONTRACEPTIVE EXOGENOUS ESTROGEN THERAPY AND BREAST-CANCER, MEDICAL JOURNAL OF AUSTRALIA 148: 217 (1988).","journal-title":"MEDICAL JOURNAL OF AUSTRALIA"},{"key":"e_1_2_1_60_1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2105\/AJPH.78.5.516","volume":"78","year":"1988","unstructured":"ROSS, R.K., PAST AND PRESENT PREFERRED PRESCRIBING PRACTICES OF HORMONE REPLACEMENT THERAPY AMONG LOS-ANGELES GYNECOLOGISTS - POSSIBLE IMPLICATIONS FOR PUBLIC-HEALTH, AMERICAN JOURNAL OF PUBLIC HEALTH 78: 516 (1988).","journal-title":"AMERICAN JOURNAL OF PUBLIC HEALTH"},{"key":"e_1_2_1_61_1","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jama.1980.03300420019018","volume":"243","year":"1980","unstructured":"ROSS, R.K., A CASE-CONTROL STUDY OF MENOPAUSAL ESTROGEN THERAPY AND BREAST-CANCER, JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 243: 1635 (1980).","journal-title":"JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION"},{"key":"e_1_2_1_62_1","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/83.18.1299","volume":"83","year":"1991","unstructured":"RUTQVIST, L.E., CONTRALATERAL PRIMARY TUMORS IN BREAST-CANCER PATIENTS IN A RANDOMIZED TRIAL OF ADJUVANT TAMOXIFEN THERAPY, JOURNAL OF THE NATIONAL CANCER INSTITUTE 83: 1299 (1991).","journal-title":"JOURNAL OF THE NATIONAL CANCER INSTITUTE"},{"key":"e_1_2_1_63_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0015-0282(16)45981-9","volume":"37","year":"1982","unstructured":"SCHIFF, I, ENDOMETRIAL HYPERPLASIA IN WOMEN ON CYCLIC OR CONTINUOUS ESTROGEN REGIMENS, FERTILITY AND STERILITY 37: 79 (1982).","journal-title":"FERTILITY AND STERILITY"},{"key":"e_1_2_1_64_1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000299035","volume":"19","year":"1985","unstructured":"SHARF, M, LIPID AND LIPOPROTEIN LEVELS FOLLOWING PURE ESTRADIOL IMPLANTATION IN POST-MENOPAUSAL WOMEN, GYNECOLOGIC AND OBSTETRIC INVESTIGATION 19: 207 (1985).","journal-title":"GYNECOLOGIC AND OBSTETRIC INVESTIGATION"},{"key":"e_1_2_1_65_1","first-page":"503","volume":"46","year":"1975","unstructured":"SILVERBERG, S.G., ENDOMETRIAL CARCINOMA IN YOUNG-WOMEN TAKING ORAL-CONTRACEPTIVE AGENTS, OBSTETRICS AND GYNECOLOGY 46: 503 (1975).","journal-title":"OBSTETRICS AND GYNECOLOGY"},{"key":"e_1_2_1_66_1","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJM197512042932302","volume":"293","year":"1975","unstructured":"SMITH, D.C., ASSOCIATION OF EXOGENOUS ESTROGEN AND ENDOMETRIAL CARCINOMA, NEW ENGLAND JOURNAL OF MEDICINE 293: 1164 (1975).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_67_1","first-page":"49","volume":"4","year":"1990","unstructured":"SPICER, D, ONCOLOGY 4: 49 (1990).","journal-title":"ONCOLOGY"},{"key":"e_1_2_1_68_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0010-7824(91)90019-C","volume":"44","year":"1991","unstructured":"SPICER, D.V., GNRH AGONISTS AS CONTRACEPTIVE AGENTS - PREDICTED SIGNIFICANTLY REDUCED RISK OF BREAST-CANCER, CONTRACEPTION 44: 289 (1991).","journal-title":"CONTRACEPTION"},{"key":"e_1_2_1_69_1","first-page":"1414","volume":"337","year":"1991","unstructured":"SPICER, D.V., OVARIAN-CANCER AND LONG-TERM TAMOXIFEN IN PREMENOPAUSAL WOMEN, LANCET 337: 1414 (1991).","journal-title":"LANCET"},{"key":"e_1_2_1_70_1","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/0002-9378(88)90591-1","volume":"159","year":"1988","unstructured":"STANCZYK, F.Z., A RANDOMIZED COMPARISON OF NONORAL ESTRADIOL DELIVERY IN POSTMENOPAUSAL WOMEN, AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 159: 1540 (1988).","journal-title":"AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY"},{"key":"e_1_2_1_71_1","first-page":"127","year":"1980","unstructured":"Studd, J. W. W., The Menopause and Postmenopause: 127 (1980).","journal-title":"The Menopause and Postmenopause"},{"key":"e_1_2_1_72_1","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1093\/jnci\/84.18.1402","volume":"84","year":"1992","unstructured":"TARONE, R.E., IMPLICATIONS OF BIRTH COHORT PATTERNS IN INTERPRETING TRENDS IN BREAST-CANCER RATES, JOURNAL OF THE NATIONAL CANCER INSTITUTE 84: 1402 (1992).","journal-title":"JOURNAL OF THE NATIONAL CANCER INSTITUTE"},{"key":"e_1_2_1_73_1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jnci\/81.14.1086","volume":"81","year":"1989","unstructured":"TURKEN, S, EFFECTS OF TAMOXIFEN ON SPINAL BONE-DENSITY IN WOMEN WITH BREAST-CANCER, JOURNAL OF THE NATIONAL CANCER INSTITUTE 81: 1086 (1989).","journal-title":"JOURNAL OF THE NATIONAL CANCER INSTITUTE"},{"key":"e_1_2_1_74_1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0140-6736(91)90417-N","volume":"338","year":"1991","unstructured":"VOIGT, L.F., PROGESTAGEN SUPPLEMENTATION OF EXOGENOUS ESTROGENS AND RISK OF ENDOMETRIAL CANCER, LANCET 338: 274 (1991).","journal-title":"LANCET"},{"key":"e_1_2_1_75_1","unstructured":"Waterhouse J. Cancer Incidence in Five Continents (1976)."},{"key":"e_1_2_1_76_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM198003063021004","volume":"302","year":"1980","unstructured":"WEISS, N.S., INCIDENCE OF ENDOMETRIAL CANCER IN RELATION TO THE USE OF ORAL-CONTRACEPTIVES, NEW ENGLAND JOURNAL OF MEDICINE 302: 551 (1980).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_77_1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1471-0528.1992.tb13853.x","volume":"99","year":"1992","unstructured":"WEN, EJO, BRIT J OBSTET GYNAEC 99: 671 (1992).","journal-title":"BRIT J OBSTET GYNAEC"},{"key":"e_1_2_1_78_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2007-1022574","volume":"1","year":"1983","unstructured":"WHITEHEAD, M, AVOIDANCE OF ENDOMETRIAL HYPERSTIMULATION IN ESTROGEN-TREATED POSTMENOPAUSAL WOMEN, SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY 1: 41 (1983).","journal-title":"SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY"},{"key":"e_1_2_1_79_1","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","volume":"136","year":"1992","unstructured":"WHITTEMORE, A.S., CHARACTERISTICS RELATING TO OVARIAN-CANCER RISK - COLLABORATIVE ANALYSIS OF 12 UNITED-STATES CASE-CONTROL STUDIES .2. INVASIVE EPITHELIAL OVARIAN CANCERS IN WHITE WOMEN, AMERICAN JOURNAL OF EPIDEMIOLOGY 136: 1184 (1992).","journal-title":"AMERICAN JOURNAL OF EPIDEMIOLOGY"},{"key":"e_1_2_1_80_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jama.1987.03390020075030","volume":"257","year":"1987","unstructured":"WINGO, P.A., THE RISK OF BREAST-CANCER IN POSTMENOPAUSAL WOMEN WHO HAVE USED ESTROGEN REPLACEMENT THERAPY, JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 257: 209 (1987).","journal-title":"JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION"},{"key":"e_1_2_1_81_1","first-page":"3680","volume":"40","year":"1980","unstructured":"YAGER, J.D., ORAL-CONTRACEPTIVE STEROIDS AS PROMOTERS OF HEPATOCARCINOGENESIS IN FEMALE SPRAGUE-DAWLEY RATS, CANCER RESEARCH 40: 3680 (1980).","journal-title":"CANCER RESEARCH"},{"key":"e_1_2_1_82_1","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJM197512042932303","volume":"293","year":"1975","unstructured":"ZIEL, H.K., INCREASED RISK OF ENDOMETRIAL CARCINOMA AMONG USERS OF CONJUGATED ESTROGENS, NEW ENGLAND JOURNAL OF MEDICINE 293: 1167 (1975).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"}],"container-title":["Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/science.8381558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T11:17:04Z","timestamp":1705317424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/science.8381558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1,29]]},"references-count":82,"journal-issue":{"issue":"5095","published-print":{"date-parts":[[1993,1,29]]}},"alternative-id":["10.1126\/science.8381558"],"URL":"https:\/\/doi.org\/10.1126\/science.8381558","relation":{},"ISSN":["0036-8075","1095-9203"],"issn-type":[{"value":"0036-8075","type":"print"},{"value":"1095-9203","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1,29]]}}}